Bispecific Antibody Market

Bispecific Antibody Market: Global Industry Analysis 2015 - 2019 and Opportunity Assessment; 2020 - 2030

Market Overview

The bispecific antibody is used for therapeutic effects by targeting two or more pathways which often lead to the root of the disease. In this, two or more antigen identifying elements are blended into one.

Bispecific antibody generates better results and minimal side effects at low cost treatment. This potential therapeutic effect of bispecific antibody against more than one disease at a time is estimated to grow bispecific antibody market. 

Bispecific antibody covers a wide spectrum of diseases like oncological, inflammatory and autoimmune disorders, rejection of organ transplants, cardiovascular diseases, allergies, ophthalmic problems and infectious diseases.

 According to WHO, the cancer and cardiovascular disorders are the leading causes of death and this unmet need of novel therapies is expected to meet by bispecific antibody therapies.

COVID-19 pandemic is expected to delay in the clinical research and subsequent launch of new therapies in the bispecific antibody market. Declining rate of hospitalization and treatment adoption are expected to impact negatively on bispecific antibody market.

In addition, the supply chain of bispecific antibody market is projected to impact owing to restriction on trading between several countries.Since 2015 when bispecific antibody market was established there has been exponential growth in terms of revenue generation.

With an increase in research and development activities for the bispecific antibody, the leading industry players are investing in the bispecific antibody. A large number of products under clinical trials will lead to the treatment of numerous disorders with a single approach making bispecific antibody market in most demand. 

High acceptance rate among clinicians and patients due to target specific treatment has boomed bispecific antibody market. With an increase in the prevalence of chronic disorders across the globe acts as a driving force for bispecific antibody market.

However, bispecific antibodies are not an exception and have side effects which limit the growth of bispecific antibody market. Blinatumomab drug type is the highest revenue-generating in the bispecific antibody market.

The bispecific antibody market is estimated to grow exponentially in the coming decade. By indication, cancer is projected as a highest revenue generating segment owing to large patient pool.

Amongst the distribution channel, the hospital pharmacies is estimated to generate highest revenue followed by retail pharmacies. Whereas, online pharmacies are expected to have significant growth rate during the forecast period with advancements in digital technology in the bispecific antibody market.

North America dominates the bispecific antibody market owing to high prevalence of chronic diseases and cancer in this region. Europe is the second-lucrative region for bispecific antibody market owing to development and launch of novel bispecific antibody products in this region.

Asia-Pacific bispecific antibody market is expected to increase substantially owing to high patient pool in the region. Latin America and Middle East & Africa bispecific antibody markets are least lucrative due to unfavourable economic conditions and less healthcare expenditure.

Some key players contributing in bispecific antibody market are

  • Sonafi S.A.
  • AbbVie Inc.
  • Pfizer Inc. 
  • Johnson & Johnson
  • Portola Pharmaceuticals 
  • Bristol-Myers Squibb
  • Ganymed Pharmaceuticals
  • OncoMed Pharmaceuticals
  • Merck Amgen 
  • Bayer AG 
  • Daiichi Sankyo Company Limited

The research report on bispecific antibody market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report on bispecific antibody market provides analysis and information according to market segments such as drug class, route of administration, application, and region.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Europe (Germany, Italy, France, U.K, Spain, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, ASEAN)
  • Oceania (Australia, New Zealand)
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
  • A neutral perspective towards market performance

bispecific antibody market Segmentation

The global bispecific antibody market is classified based on drug type, indication, distribution channel and region.

By drug type

  • Blinatumomab
  • Catumaxomab
  • Duligotumab 

By indication

  • Cancer
  • Infectious Disease
  • Inflammatory and Autoimmune Disorders
  • CNS Disorders

By distribution channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drugstores
  • Online Pharmacies

Need specific information?

In the news

How Businesses Can Utilize Market Research to Create Reactive, Recession-proof Strategies for Survival

by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights

Our Clients

View Our Reports from Healthcare

View Reports

Recommendations

Bispecific Antibody Market